Immunovant shares owned by Martingale Asset Management
Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Martingale Asset Management
from 13F filings
Historical chart of Martingale Asset Management investment in Immunovant
Tip: Access up to 7 years of quarterly data
All positions including Immunovant held by Martingale Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Immunovant by Martingale Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $462k | 19k | 24.84 |
| 2023-03-31 | $335k | 22k | 15.51 |
| 2022-12-31 | $705k | 40k | 17.75 |
| 2022-09-30 | $392k | 70k | 5.59 |
| 2022-06-30 | $274k | 70k | 3.91 |
| 2022-03-31 | $386k | 70k | 5.51 |
| 2021-12-31 | $527k | 62k | 8.52 |
| 2021-09-30 | $513k | 59k | 8.70 |
| 2021-06-30 | $207k | 20k | 10.60 |
More positions owned by Martingale Asset Management
View all positions for Martingale Asset Management